VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.18
Tradestie Score
57
Market Cap
$108.92M
Revenue Growth
5.0%
Analyst Upside
+459.3%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRZN
Surrozen, Inc. Common
|
$31.67
|
$117.07M | - | 30 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$4.81
|
$114.01M | - | 57 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$30.62
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.55
|
$97.42M | - | 50 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.22
|
$84.52M | - | 40 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.07
|
$67.94M | - | 52 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$20.69
|
$62.81M | - | 49 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$0.44
|
$46.20M | - | 49 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$1.61
|
$34.77M | - | 36 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$1.66
|
$4.78M | - | 45 | Compare |
More VTGN Analysis
Data updated: Nov 13, 2026 | Industry: Biotechnology (SIC 2834)
222 stocks in this industry